Literature DB >> 2180291

Hypertension in the Hispanic-American population.

P V Caralis1.   

Abstract

According to the 1988 census, there are 19.4 million Hispanics living in the United States. They represent 8.1 percent of the nation's population, and that percentage is expected to rise significantly in the next 25 years. Demographic projections indicate that Hispanics will become the largest minority group in the United States by the year 2000, yet they remain a seriously understudied population. This article examines available clinical data, epidemiologic findings, and sociologic observations regarding the incidence of hypertension in this minority group and summarizes what is known about the detection, evaluation, treatment, and control of high blood pressure in Hispanics. In addition, the preliminary results of a multi-center, placebo-controlled trial comparing the efficacy and safety of a potassium-sparing diuretic (Dyazide; Smith Kline & French Laboratories) in Hispanic-American patients with mild-to-moderate hypertension are presented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180291     DOI: 10.1016/0002-9343(90)90004-w

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Physical activity guideline in Mexican-Americans: does the built environment play a role?

Authors:  Abiodun O Oluyomi; Lawrence W Whitehead; Keith D Burau; Elaine Symanski; Harold W Kohl; Melissa Bondy
Journal:  J Immigr Minor Health       Date:  2014-04

2.  Adjusting for nonresponse bias in a health examination survey.

Authors:  M L Rowland; R N Forthofer
Journal:  Public Health Rep       Date:  1993 May-Jun       Impact factor: 2.792

Review 3.  Clinical trials and transethnic pharmacology.

Authors:  M E Kitler
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

4.  Essential hypertension of Caribbean Hispanics: sodium, renin, and response to therapy.

Authors:  Cheryl L Laffer; Fernando Elijovich
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jul-Aug       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.